Workflow
新华医疗: 新华医疗2025年半年度报告摘要

Core Viewpoint - The financial performance of Shandong Xinhua Medical Equipment Co., Ltd. has shown a decline in revenue and profit for the first half of 2025 compared to the previous year, indicating potential challenges in the company's operations and market conditions [1]. Financial Summary - Total assets at the end of the reporting period amounted to CNY 15.35 billion, a decrease of 1.15% from the previous year [1]. - Net assets attributable to shareholders increased to CNY 7.86 billion, reflecting a growth of 3.41% year-on-year [1]. - Operating revenue for the period was CNY 4.79 billion, down 7.64% compared to CNY 5.19 billion in the same period last year [1]. - Total profit decreased by 19.91% to CNY 454.48 million from CNY 567.47 million [1]. - Net profit attributable to shareholders fell by 20.35% to CNY 385.72 million, compared to CNY 484.26 million in the previous year [1]. - The net profit after deducting non-recurring gains and losses was CNY 242.75 million [1]. - The net cash flow from operating activities increased significantly by 76.86% to CNY 137.26 million [1]. - The weighted average return on net assets decreased by 1.51 percentage points to 4.99% [1]. - Basic and diluted earnings per share dropped by 35.35% to CNY 0.64 [1]. Shareholder Information - The total number of shareholders at the end of the reporting period was 39,279 [1]. - Major shareholders include Shandong Yiyang Health Industry Development Group Co., Ltd. with a holding of 28.91% and Shandong State-owned Assets Investment Holdings Co., Ltd. with 4.15% [2].